(old) Ralph Moss Reports

[Guest guest]

Ralph Moss Reports

 

 

Media Attacks Doctor Showing Nutritional Benefits to Cancer PatientsThe question

of the week at The Moss Reports is one of the most important we have ever had to

deal with:

http://www.ralphmoss.com/qanda/question012200.shtml

It concerns a vicious, front-page attack in the Washington Post last Tuesday on

Nicholas Gonzalez, M.D. Dr. Gonzalez is a New York physician who treats advanced

cancer through diet and detoxification. He has published the results of a Phase

One clinical trial in pancreatic cancer. This was quite positive. (Nutrition and

Cancer 1999;33:117-124). The National Institutes of Health were impressed enough

to put $1.4 million into a more extensive trial at Columbia University. That

trial has been slow to get off the ground, for technical reasons.

The fact that this " quack treatment " is being taken seriously by the government

has enraged some defenders of the status quo. Their worst nightmare is that the

nutritional approach to cancer will be vindicated at Columbia, ushering in a new

era in oncology. This new era will look on them as dinosaurs. I believe the

Washington Post article is timed and positioned to derail the Columbia clinical

trial.

Somewhere in the back of my mind I thought that the new millennium might usher

in an age of peace and harmony in the cancer field. No such luck. Obviously, the

struggle continues.

Have a peaceful and productive week,

Ralph W. Moss, Ph.D.

 

Vitamin C Causes New Kind of Cancer Cell Death The question of the week at The

Moss Report concerns antioxidants. One of the first readers of Antioxidants

Against Cancer has checked in with several penetrating questions about a

substance called MPG-2 as well as the use of herbs along with antioxidants.

Check out the question and my answer at:

http://www.ralphmoss.com/qanda/question010800.shtml

As if on cue, the oncology community has chosen this time to mount a big

campaign against the use of antioxidants, especially at the same time as

chemotherapy. I have not seen such biased coverage in many years. It is

interesting to me how scientists at a meeting who draw negative conclusions

about antioxidants are given national publicity, while others at the same

meeting who find merit in antioxidants are totally ignored. I am referring to

the work of Jacques Gilloteaux, D.Sc., who presented his latest findings at the

American Society of Cell Biology in Washington, D.C., in December, 1999.

He and his student, David Arnold, observed a new type of cell death that occurs

when cancer cells are treated with vitamin C as well as vitamin K3. This newly

observed type of cell death is called autoschizis. Treatment resulted in a

reduction in tumor size and an extension of life span in the test mice. The

researchers have made similar findings for breast and ovarian cancer. Dr.

Gilloteaux would like to develop the vitamin mixture as an additional cancer

treatment along with radiation and chemotherapy. This has been virtually

ignored, while an anti-vitamin C study published at the same meeting was wildly

publicized.

Also, check out the article in the Journal of the National Cancer Institute

(JNCI, Jan. 5, 2000, pp. 42-47) on the use of alternative therapies by women

with breast cancer in four ethnic populations. " More than 90 percent of the

patients found the therapies helpful and would recommend them to their friends. "

How many types of conventional medicine can make the same claim?

Have a peaceful and productive week,

Ralph W. Moss, Ph.D.

 

 

Sample Letter to the Editor

Dear Friend,

Many of you are as upset as I am about the Washington Post attack on Dr.

Nicholas Gonzalez. (See the Question of the Week at my website,

www.ralphmoss.com) Some of you have asked what you can do about it. I suggest

that you send a letter to the editor of the Post. There is an easy way to do

this at:

http://www.washingtonpost.com/wp-srv/edit/letters/letterform.htm

You might suggest that they offer equal space to Dr. Gonzalez himself to defend

his character and his innovative approach to cancer.

The following is my own letter to the editor expressing my outrage:

 

Dear Editor:

Your front-page article (Jan. 18) on Nicholas Gonzalez, M.D. is a hatchet job.

Susan Okie quotes opponents of alternative medicine but ignore doctors who could

have defended Gonzalez. She claims that Gonzalez " does not use standard tests to

monitor the treatment's effectiveness. " But most of his patients have the same

tests that other cancer patients receive, as a glance at his files would have

shown her.

She disparages Gonzalez's training but fails to mention that he did postdoctoral

work under the former president of Sloan-Kettering Institute. She reports that

Gonzalez was disciplined by the New York Medical Board but fails to quote

favorable comments in his disciplinary report. Incidentally, this sort of

harassment of alternative doctors has now been forbidden by law in New York.

While critics are given their due, supporters are treated disparagingly. For

instance, Karen Antman, M.D. is not identified as past president of the American

Society of Oncology and member of the Editorial Board of the New England Journal

of Medicine.

Okie ridicules the idea that orally ingested enzymes can be absorbed into the

bloodstream, but ignores considerable European research demonstrating this. She

implies that Gonzalez's pancreatic cancer patients did not really have cancer.

Yet they all came from conventional medical centers with biopsies and X rays.

This is not the first time that patients who respond well to alternative

treatments have had their diagnoses unfairly called into question.

Ralph W. Moss, Ph.D.

 

 

I will let you know if this is accepted for publication.

Best regards,

RWM

 

 

Gettingwell- / Vitamins, Herbs, Aminos, etc.

 

To , e-mail to: Gettingwell-

Or, go to our group site: Gettingwell

 

 

 

 

Tax Center - forms, calculators, tips, and more